Skip to content
  • 6,816 federal solicitations are open right now. How many of them are yours?
  • New solicitations are posted every day. The ones you never saw are the ones you cannot win.
  • Stop checking SAM.gov every morning. Let the contracts that fit your business come to you.
  • Tell Abierto what you sell in one sentence. AI reads every open solicitation for you.
  • Deadlines are short. Hear about a solicitation the day it is posted, not the week it closes.
  • Amendments move deadlines. Watch a solicitation and Abierto tells you when it changes.
  • See which contracts in your field are about to end, and who holds them today.
  • Plans from $39 a month. See your matches before you pay.
See plans
AbiertoGet started
Menu

Award notice

SUPPLY of LUTATHERA® (lutetium Lu 177 dotatate) and PLUVICTO™ (lutetium Lu 177 vipivotide tetraxetan)

12481254

Defense Health Agency (Dha), Defense Health Agency.

View on SAM.gov Markdown

Awarded

Novartis Pharmaceuticals Corporation

$480,119.64 on the award notice, September 30, 2026, contract HT001426FE141

Get the next one like this from Defense Health Agency (Dha) by email, the day it is posted.Find my opportunities

Description

As published on SAM.gov.

Clinical Utility: It is used for targeted radioligand therapy for specific types of prostate cancer within the Nuclear Medicine Division of the Department of Radiology at WRNMMC. Novartis Pharmaceuticals Corporation is the sole source for Pluvicto. Therefore, the recommended course of action is to award a contract directly to Novartis. This approach is deemed to be in the government's best interest to ensure the seamless delivery of these critical supplies and maintain continuity of patient care at WRNMMC. The acquisition will be treated as a sole-source procurement.

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. October 8, 2026

    Award notice

    Awarded to Novartis Pharmaceuticals Corporation for $480,120. SAM.gov, notice b282dc9e8acc4a928ab3a5823a5dd0f3

    1 revisions on SAM
    • October 8, 2026: publish, award notice